Health Care & Life Sciences » Pharmaceuticals | Nanobac Pharmaceuticals Inc.

Nanobac Pharmaceuticals Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2003
2004
2005
2006
2007
Sales/Revenue
482.80
358.40
656.80
225.10
17.60
Cost of Goods Sold (COGS) incl. D&A
514.20
817.50
989.40
621.10
474.80
Gross Income
31.40
459.20
332.60
396.00
457.20
SG&A Expense
2,668.80
7,141.20
2,505.10
3,833.50
4,457.60
Unusual Expense
-
-
-
585.00
1,560.00
Non Operating Income/Expense
21.50
30.90
778.80
40.20
85.60
Interest Expense
42.90
248.10
70.90
199.00
186.90
Pretax Income
2,764.70
7,817.50
3,687.30
4,973.40
6,576.10
Consolidated Net Income
2,764.70
7,817.50
3,687.30
4,973.40
6,576.10
Net Income
2,761.10
7,817.50
3,687.30
4,973.40
6,576.10
Net Income After Extraordinaries
1,822.80
7,760.20
3,687.30
4,973.40
6,576.10
Net Income Available to Common
2,761.10
7,817.50
3,687.30
4,973.40
6,576.10
EPS (Basic)
0.05
0.05
0.02
0.02
0.03
Basic Shares Outstanding
67,489.50
152,903.10
188,859.00
199,425.50
245,197.50
EPS (Diluted)
0.05
0.05
0.02
0.02
0.03
Diluted Shares Outstanding
67,489.50
152,903.10
188,859.00
199,425.50
245,197.50
EBITDA
2,519.10
6,883.30
2,077.80
3,688.30
4,454.50
Minority Interest Expense
3.50
-
-
-
-

About Nanobac Pharmaceuticals

View Profile
Address
5025 West Lemon Street
Tampa Florida 33609
United States
Employees -
Website -
Updated 07/08/2019
Owns and operates community health centers .

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.